skip navigation
| | Text Size: -A | A | A+


This is a picture of the coronavirus

CPMC Begins New Monoclonal Antibody Therapy Program


Beginning the week of January 18, Cabinet Peaks Medical Center will be offering another new line of defense for the public in the fight against COVID-19. Monoclonal Antibody Therapy, also known as Bamlanivimab helps to quick start the immune system to build up antibodies to fight COVID-19.

Monoclonal Antibody Therapy is only for people who have recently been diagnosed with COVID-19 who meet very specific medical criteria. It is administered through a one-hour infusion which is followed by a required one-hour observation period during which time the patient must remain with the infusion nurse at Cabinet Peaks Medical Center.

This therapeutic service is a one-time treatment for patients. It has been known to lead to a better patient outcome and to help avoid hospitalization and severe illness for people with COVID-19.
For more questions about Monoclonal Antibody Therapy, or to find out if you qualify for this treatment, please reach out to your primary care provider.